)
)
Isofol Medical Investor Relations Material
Latest events
Investor Update
Isofol Medical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Isofol Medical
Access all reports
Segment Data
Access more data
Revenue by
Geography
Asia
Expenses by
Financials
Isofol Medical operates as a clinical stage biotech company that develops and commercializes oncology drugs. Its products include arfolitixorin, which is in phase 3 clinical trial for the treatment of colorectal cancer; pentosan sulfate sodium, which has completed a phase 2 clinical trial for ovarian cancer or recurrent bladder cancer indication; new chemical entities, preclinical NCEs; monoclonal antibodies, which are being investigated for immunotherapy treatment of different types of cancer.
Key slides for Isofol Medical
Investor Meeting
Isofol Medical
Investor Meeting
Isofol Medical
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ISOFOL
Country
🇸🇪 Sweden